Although Smc3/Bcl6 tumors showed higher variability in the total numbers of somatic mutations, these were not significantly different than tumor cells from the Bcl6 (Wilcoxon p=0.24, Figure 5A). The gene discussed is SMC3; the disease is neoplasm.